BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 19009273)

  • 21. Efficient replication systems for hepatitis C virus using a new human hepatoma cell line.
    Kato N; Mori K; Abe K; Dansako H; Kuroki M; Ariumi Y; Wakita T; Ikeda M
    Virus Res; 2009 Dec; 146(1-2):41-50. PubMed ID: 19720094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel helper-dependent adenovirus-based cell culture model for Hepatitis C virus replication and production.
    Zhou X; Zeng Y; Li J; Guo Y; Fu Y; He J; Sun S; Zhou Y
    Virol J; 2013 Aug; 10():273. PubMed ID: 23987099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Establishment of Replication-Competent HCV Strain with Minimum Modifications.
    Kato T; Murayama A; Wakita T
    Methods Mol Biol; 2019; 1911():73-83. PubMed ID: 30593618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [HCV replication in Huh-7.5 cell line].
    Komorowski M; Kołakowska A; Godzik P; Madaliński K
    Med Dosw Mikrobiol; 2012; 64(3):239-44. PubMed ID: 23285778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Production of infectious hepatitis C virus of various genotypes in cell cultures.
    Kato T; Matsumura T; Heller T; Saito S; Sapp RK; Murthy K; Wakita T; Liang TJ
    J Virol; 2007 May; 81(9):4405-11. PubMed ID: 17301131
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multiple effects of Honokiol on the life cycle of hepatitis C virus.
    Lan KH; Wang YW; Lee WP; Lan KL; Tseng SH; Hung LR; Yen SH; Lin HC; Lee SD
    Liver Int; 2012 Jul; 32(6):989-97. PubMed ID: 22098176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Highly efficient JFH1-based cell-culture system for hepatitis C virus genotype 5a: failure of homologous neutralizing-antibody treatment to control infection.
    Jensen TB; Gottwein JM; Scheel TK; Hoegh AM; Eugen-Olsen J; Bukh J
    J Infect Dis; 2008 Dec; 198(12):1756-65. PubMed ID: 19032070
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cell culture and infection system for hepatitis C virus.
    Kato T; Date T; Murayama A; Morikawa K; Akazawa D; Wakita T
    Nat Protoc; 2006; 1(5):2334-9. PubMed ID: 17406476
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems.
    Gottwein JM; Bukh J
    Adv Virus Res; 2008; 71():51-133. PubMed ID: 18585527
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infection of human hepatocyte chimeric mouse with genetically engineered hepatitis C virus and its susceptibility to interferon.
    Hiraga N; Imamura M; Tsuge M; Noguchi C; Takahashi S; Iwao E; Fujimoto Y; Abe H; Maekawa T; Ochi H; Tateno C; Yoshizato K; Sakai A; Sakai Y; Honda M; Kaneko S; Wakita T; Chayama K
    FEBS Lett; 2007 May; 581(10):1983-7. PubMed ID: 17466983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interference of hepatitis C virus RNA replication by short interfering RNAs.
    Kapadia SB; Brideau-Andersen A; Chisari FV
    Proc Natl Acad Sci U S A; 2003 Feb; 100(4):2014-8. PubMed ID: 12566571
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.
    Cai Z; Zhang C; Chang KS; Jiang J; Ahn BC; Wakita T; Liang TJ; Luo G
    J Virol; 2005 Nov; 79(22):13963-73. PubMed ID: 16254332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patient-derived hepatitis C virus and JFH-1 clones differ in their ability to infect human hepatoma cells and lymphocytes.
    Sarhan MA; Chen AY; Russell RS; Michalak TI
    J Gen Virol; 2012 Nov; 93(Pt 11):2399-2407. PubMed ID: 22855787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Centrifugal enhancement of hepatitis C virus infection of human hepatocytes.
    Ye L; Wang X; Wang S; Luo G; Wang Y; Liang H; Ho W
    J Virol Methods; 2008 Mar; 148(1-2):161-5. PubMed ID: 18178263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Casein kinase II inhibitor enhances production of infectious genotype 1a hepatitis C virus (H77S).
    Kim S; Jin B; Choi SH; Han KH; Ahn SH
    PLoS One; 2014; 9(12):e113938. PubMed ID: 25464014
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Robust production of infectious viral particles in Huh-7 cells by introducing mutations in hepatitis C virus structural proteins.
    Delgrange D; Pillez A; Castelain S; Cocquerel L; Rouillé Y; Dubuisson J; Wakita T; Duverlie G; Wychowski C
    J Gen Virol; 2007 Sep; 88(Pt 9):2495-2503. PubMed ID: 17698659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome.
    Wakita T; Pietschmann T; Kato T; Date T; Miyamoto M; Zhao Z; Murthy K; Habermann A; Kräusslich HG; Mizokami M; Bartenschlager R; Liang TJ
    Nat Med; 2005 Jul; 11(7):791-6. PubMed ID: 15951748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of persistent HCV genotype 3a infection cell culture model in huh-7 cell.
    Asad S; Ijaz B; Ahmad W; Kausar H; Sarwar MT; Gull S; Shahid I; Khan MK; Hassan S
    Virol J; 2012 Jan; 9():11. PubMed ID: 22234052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro.
    Lindenbach BD; Meuleman P; Ploss A; Vanwolleghem T; Syder AJ; McKeating JA; Lanford RE; Feinstone SM; Major ME; Leroux-Roels G; Rice CM
    Proc Natl Acad Sci U S A; 2006 Mar; 103(10):3805-9. PubMed ID: 16484368
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cell culture systems for the hepatitis C virus.
    Bartenschlager R; Lohmann V
    Antiviral Res; 2001 Oct; 52(1):1-17. PubMed ID: 11530183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.